Vemurafenib in patients with metastatic malignant melanoma.

被引：0
|
作者：
Ocvirk, Janja
Mesti, Tanja
Boc, Marko
Rebersek, Martina
机构：
[1] Inst Oncol, Ljubljana, Slovenia
[2] Inst Oncol Ljubljana, Ljubljana, Slovenia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20121
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Treatment with vemurafenib in patients with metastatic melanoma.
    Ocvirk, Janja
    Boc, Marko
    Mesti, Tanja
    Rebersek, Martina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] An imaging study of vemurafenib in patients with BRAFV600-mutated metastatic melanoma.
    Lastoria, Secondo
    Grimaldi, Antonio M.
    Aloj, Luigi
    Simeone, Ester
    Romano, Anna
    Caraco, Corradina
    Curvietto, Marcello
    Esposito, Assunta
    Caraco, Corrado
    Mozzillo, Nicola
    Torri, Valter
    Ascierto, Paolo Antonio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] BRAFV600 mutation levels and response to vemurafenib in metastatic melanoma.
    Lebbe, Celeste
    Howkit, Alexandre
    Sadoux, Aurelie
    Podgorniak, Marie Pierre
    Battistella, Maxime
    Pages, Cecile
    Roux, Jennifer
    Porcher, Raphael
    Tost, Jorg
    Mourah, Samia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] Metastatic malignant melanoma. Successfull treatment with ipilimumab
    Jansen, T.
    Bruch-Gerharz, D.
    Reifenberger, J.
    Schulte, K. W.
    [J]. HAUTARZT, 2013, 64 (04): : 228 - +
  • [5] Prolonged survival in a patient with metastatic malignant melanoma.
    Ferri, RM
    Thomas, P
    Tramier, H
    Guidicelli, R
    Kleisbauer, JP
    [J]. REVUE DES MALADIES RESPIRATOIRES, 1999, 16 (02) : 204 - 205
  • [6] Treatment of Metastatic Malignant Melanoma With Vemurafenib During Pregnancy
    Maleka, Aglaia
    Enblad, Gunilla
    Sjors, Gunnar
    Lindqvist, Anna
    Ullenhag, Gustav J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (11) : E192 - E193
  • [7] Long-Term Response to Vemurafenib Therapy in Patients with metastatic malignant Melanoma
    Groffik, A.
    Mueller-Brenne, T.
    Rudolph, B.
    Rietz, S.
    Grabbe, S.
    Loquai, C.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 (09): : 908 - 908
  • [8] DRESS under a targeted Combination Therapy with Vemurafenib and Cobimetinib in Patients with metastatic malignant Melanoma
    Gschnell, M.
    Pickert, J.
    Logenthiran, L.
    Bender, A.
    Pfuetzner, W.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 42 - 43
  • [9] A single-arm, open-label, US expanded access study of vemurafenib in patients with metastatic melanoma.
    Schuchter, Lynn Mara
    Flaherty, Lawrence E.
    Hamid, Omid
    Linette, Gerald P.
    Hallmeyer, Sigrun
    Gonzalez, Rene
    Cowey, Charles Lance
    Pavlick, Anna C.
    Kudrik, Fred J.
    Lawson, David H.
    Margolin, Kim Allyson
    Ribas, Antoni
    McDermott, David F.
    Khatcheressian, James L.
    Flaherty, Keith T.
    Day, Bann-Mo
    Linke, Rolf Gerhard
    Hainsworth, John D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] Mechanisms of elevated serum creatinine in patients receiving vemurafenib for advanced melanoma.
    Hurabielle, Charlotte
    Pillebout, Evangeline
    Stehle, Thomas
    Pages, Cecile
    Roux, Jennifer
    Schneider, Pierre
    Chevret, Sylvie
    Mourah, Samia
    Basset-Seguin, Nicole
    Chaffaut, Cendrine
    Vidal-Petiot, Emmanuelle
    Flamant, Martin
    Lebbe, Celeste
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345